Tampa General Hospital (TGH) Cancer Institute | Cancer Center of South Florida (CCSF) welcomes board-certified medical oncologist Dr. Adam J. Kotkiewicz to its practice. He specializes in treating patients with prostate, bladder, kidney, testicular, ureter, and penile cancers. He also practices benign hematology – the diagnosis and management of noncancerous blood disorders.
Kotkiewicz earned his medical degree from the Philadelphia College of Osteopathic Medicine. He completed his residency in internal medicine at Lehigh Valley Hospital in Allentown, PA, and his fellowship in hematology and oncology at Penn State Milton S. Hershey Medical Center in Hershey, PA. Kotkiewicz most recently practiced with Martin Health Physicians Group, Cleveland Clinic Florida, Jupiter Medical Center, and Lehigh Valley Physicians Group, Lehigh Valley Hospital.
“It’s a privilege to join a nationally respected team of cancer specialists known for their innovation, collaboration, and steadfast commitment to compassionate, patient-centered care,” Kotkiewicz said.
“Adam has many years of experience treating patients in both Palm Beach and Martin counties. He will be a tremendous addition to our expanding practice as we continue to bring revolutionary cancer care to patients across the Palm Beaches and on the Treasure Coast,” said Dr. Abraham Schwarzberg, executive vice president, chief of oncology at Tampa General Hospital and TGH Cancer Institute | CCSF, president, Tampa General Provider Network and co-vice president, clinical and translational research, TGH | USF Health Office of Clinical Research.
Experts at TGH Cancer Institute | CCSF collaborate to provide comprehensive treatment options. Since 2020, Tampa General Hospital has been creating a framework of state-of-the-art services for patients in Palm Beach County and on the Treasure Coast with the expertise and innovation of a preeminent academic health system.
One of the few Florida cancer centers backed by academic medicine, the TGH Cancer Institute has been named Top 10% in the Nation for Cancer Care by U.S. News & World Report’s 2025-26 Best Hospitals and is named one of America’s Best Cancer Hospitals by Newsweek for 2025. The institute provides comprehensive care via groundbreaking therapies, advanced diagnostic imaging tools and a highly coordinated, interdisciplinary approach to world-class patient care. It is certified by the American College of Surgeons’ Commission on Cancer Accreditation and by the American Society of Clinical Oncology (ASCO) for meeting the strict standards required by the society’s Quality Oncology Practice Initiative (QOPI) program. For more information about the TGH Cancer Institute, visit www.tgh.org/cancer.